Recent News

• 08.26.2025 - National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
• 08.13.2025 - Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
• 08.07.2025 - Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results
• 08.07.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 06.17.2025 - Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results
• 06.17.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.22.2025 - Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Recent Filings

• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.11.2025 - DEF 14A Other definitive proxy statements
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.17.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 06.17.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 04.28.2025 - 8-K Current report
• 04.28.2025 - EX-99.1 EX-99.1